Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Hepatitis B Virus Studies, and Hepatocellular Carcinoma Treatment and Prognosis.
Prediction of Postoperative Intravesical Recurrence Using Urine DNA Monitoring in Nonmuscular-Invasive Urothelial Bladder Cancer.
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
Reply to letter to the editor "Comment on: "Hepatic immune-related adverse event increased the overall survival of patients with malignancies treated with immune checkpoint inhibitors"".
Reply to Letter to the Editor "Hepatic irAE, ICI continuation, and survival: need for robust evidence beyond initial observations".
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024
Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer.
Elucidation of genomic origin of synchronous endometrial and ovarian cancer (SEO) by genomic and microsatellite analysis.
Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy
Acute variceal bleeding portends poor outcomes in patients with acute-on-chronic liver failure: a propensity score matched study from the APASL ACLF Research Consortium (AARC)
Molecular analysis of ascitic fluid cytology reflects genetic changes of malignancies of the ovary equivalent to surgically resected specimens.
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission
APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions
Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update
APASL consensus statements and recommendation on treatment of hepatitis C
APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing
Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis
Safety and efficacy of ledipasvir/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or older
STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection
APASL consensus statements and management algorithms for hepatitis C virus infection